BioSpace News Archive

Preparing for Your Annual Performance Review

Accomplishments are integral to the aspects of the annual performance review. And here’s how to prepare for review to admit a good performance record in the company.

November 11, 2019
·
4 min read
·
Katharine Hansen, PhD
Business

Expesicor receives SBIR award from the National Institutes of Health’s HEAL Initiative to develop an objective pain measurement tool

This technology is applicable to both personalized pain treatment and the development of novel pain management therapies, such as non-opioid medications.

November 11, 2019
·
3 min read
Deals

Sandoz Boosts Toehold in Japan with Aspen Acquisition

Novartis said the acquisition will enable Sandoz to expand its presence in the third-largest worldwide generics marketplace.

November 11, 2019
·
2 min read
·
Alex Keown
Deals

Expedeon AG signs EUR 120 million deal with Abcam for the sale of its immunology and proteomics business

Expedeon AG announces the signing of an agreement with Abcam plc, Cambridge, UK, to sell its proteomics and immunology business activities for a cash payment of EUR 120 million.

November 11, 2019
·
5 min read
Business

evitria Opens its New Head Office in Scandinavia

evitria AG, a global antibody expression service provider, announces the opening of its new head office in Denmark to better serve the growing demand from Scandinavian enterprises.

November 11, 2019
·
1 min read
Policy

F2G Receives US FDA Breakthrough Therapy Designation for Olorofim

In Phase 2b development for the treatment of life-threatening fungal infections

November 11, 2019
·
4 min read
ORYX Confirms ParvOryx Mode of Action in Tumor Explant Model

ORYX, a translational medicine company focused on oncolytic virotherapy and cancer vaccines, reported new results on the mode of action of oncolytic virus ParvOryx in human ovarian cancer explants.

November 11, 2019
·
4 min read
Business

LEO Pharma announces agreement with Ubiquigent to access novel compounds

Ubiquigent Limited and LEO Pharma A/S announced that they have entered into an option agreement granting LEO Pharma access to two novel compounds.

November 11, 2019
·
3 min read
Business

Partner Magenta Therapeutics Exercises Option to Further Develop Antibody Targeted Amanitin Conjugates Targeted to CD45

Heidelberg Pharma AG announced that its partner Magenta Therapeutics, Cambridge, MA, USA, declared that it will exercise the option for the exclusive worldwide development and marketing rights for Antibody Targeted Amanitin Conjugates targeting CD45.

November 11, 2019
·
3 min read
Business

Kaiser Permanente CEO Bernard Tyson, a Champion of Affordable Health Care, Dies Unexpectedly

Tyson served as CEO of Kaiser Permanente since 2013 and spent more than 30 years with the nonprofit healthcare giant.

November 11, 2019
·
3 min read
·
Alex Keown